Matthew Gray

Matthew Gray is an experienced professional in the pharmaceutical industry, currently serving as the Director of CMC Program Management at Bicycle Therapeutics since March 2020. Prior to this role, Matthew Gray worked at GlaxoSmithKline from 1996 to October 2019, holding positions such as Scientific Leader in API Chemistry and Exploratory Development Sciences, as well as Principal Scientist, Investigator, and Manager in Synthetic Chemistry. Matthew Gray earned a PhD in Organic Chemistry from the University of Waterloo and a BSc in Chemistry from the University of Southampton. Additionally, Matthew Gray completed studies at the University of Reading.